Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Milind A. Phadnis, Joaquina Celebre Baranda, Haoran Li, Gregory James Crane, Jeremy Robert Flanagan, Deepti Satelli, Erin Carroll, Cathey Belcher, Shannon Bradbury, Marc Thomas Roth, Sean Kumer, Timothy Schmitt, Clay King, Mojtaba Olyaee, Amit Rastogi, Reza Hejazi, Lauren Clark, Weijing Sun. "A phase II open-label study of enfortumab vedotin in patients with previously treated locally advanced, recurrent, or metastatic pancreatic adenocarcinoma (EPIC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.730